keyword
MENU ▼
Read by QxMD icon Read
search

Live allograft bone cells

keyword
https://www.readbyqxmd.com/read/27765715/an-allograft-generated-from-adult-stem-cells-and-their-secreted-products-efficiently-fuses-vertebrae-in-immunocompromised-athymic-rats-and-inhibits-local-immune-responses
#1
Bret H Clough, Eoin P McNeill, Daniel Palmer, Ulf Krause, Thomas J Bartosh, Christopher D Chaput, Carl A Gregory
BACKGROUND CONTEXT: Spine pain and the disability associated with it are epidemic in the United States. According to the National Center for Health Statistics, more than 650,000 spinal fusion surgeries are performed annually in the United States, and yet there is a failure rate of 15%-40% when standard methods employing current commercial bone substitutes are used. Autologous bone graft is the gold standard in terms of fusion success, but the morbidity associated with the procedure and the limitations in the availability of sufficient material have limited its use in the majority of cases...
October 17, 2016: Spine Journal: Official Journal of the North American Spine Society
https://www.readbyqxmd.com/read/27677902/endemic-impact-of-human-t-cell-leukemia-virus-type-1-screening-in-bone-allografts
#2
Yasuhiro Ishidou, Kanehiro Matsuyama, Eiji Matsuura, Takao Setoguchi, Satoshi Nagano, Hironori Kakoi, Masataka Hirotsu, Ichiro Kawamura, Takuya Yamamoto, Setsuro Komiya
Allograft bone is a widely used as a convenient tool for reconstructing massive bone defects in orthopedic surgery. However, allografts are associated with the risk of viral disease transmission. One of the viruses transmitted in this manner is human T-lymphotropic virus type 1 (HTLV-1), which is found worldwide but is unevenly distributed. The southwestern parts of Japan are a highly endemic for HTLV-1. We investigated the HTLV-1 seroprevalence in candidate allograft donors at the regional bone bank in Kagoshima, Japan during its first 5 years of service...
September 27, 2016: Cell and Tissue Banking
https://www.readbyqxmd.com/read/27665406/-renal-transplantation-in-2046-future-and-perspectives
#3
M-O Timsit, J Branchereau, R Thuret, F Kleinclauss
OBJECTIVES: To report major findings that may build the future of kidney transplantation. MATERIAL AND METHODS: Relevant publications were identified through Medline (http://www.ncbi.nlm.nih.gov) and Embase (http://www.embase.com) database from 1960 to 2016 using the following keywords, in association, "bio-engineering; heterotransplantation; immunomodulation; kidney; regenerative medicine; xenotransplantation". Articles were selected according to methods, language of publication and relevance...
September 21, 2016: Progrès en Urologie
https://www.readbyqxmd.com/read/27241476/outcomes-of-pediatric-identical-living-donor-liver-and-hematopoietic-stem-cell-transplantation
#4
Steffen Hartleif, Peter Lang, Rupert Handgretinger, Tobias Feuchtinger, Jörg Fuchs, Alfred Königsrainer, Silvio Nadalin, Ekkehard Sturm
Chronic IS is associated with significant morbidity in transplant recipients. Moreover, IS does not prevent chronic graft failure frequently. Allograft immune tolerance in LT can be induced by complete donor chimerism through allogenic HSCT combined with identical LDLT. This approach may exempt patients from chronic lifelong IS. However, it is unclear whether its benefits justify its risks. Here, we present three cases from our institution and analyze seven additional reports of children treated with HSCT/LDLT, all receiving HSCT due to hemato-oncological indications...
November 2016: Pediatric Transplantation
https://www.readbyqxmd.com/read/27174392/an-injectable-hydrogel-as-bone-graft-material-with-added-antimicrobial-properties
#5
Giacomo Tommasi, Stefano Perni, Polina Prokopovich
Currently, the technique which provides the best chances for a successful bone graft, is the use of bone tissue from the same patient receiving it (autograft); the main limitations are the limited availability and the risks involved in removing living bone tissue, for example, explant site pain and morbidity. Allografts and xenografts may overcome these limitations; however, they increase the risk of rejection. For all these reasons the development of an artificial bone graft material is particularly important and hydrogels are a promising alternative for bone regeneration...
June 2016: Tissue Engineering. Part A
https://www.readbyqxmd.com/read/27057635/differential-effects-of-lenalidomide-during-plasma-cell-differentiation
#6
Michel Jourdan, Maïlys Cren, Peter Schafer, Nicolas Robert, Christophe Duperray, Laure Vincent, Patrice Ceballos, Guillaume Cartron, Jean-François Rossi, Jérôme Moreaux, Rajesh Chopra, Bernard Klein
Thalidomide, lenalidomide and pomalidomide have greatly improved the outcome of patients with multiple myeloma. However, their effects on plasma cells, the healthy counterpart of myeloma cells, are unknown. Here, we investigated lenalidomide effects on normal human plasma cell generation using an in vitro model. Lenalidomide inhibited the generation of pre-plasmablasts and early plasma cells, while it moderately affected plasmablast production. It also reduced the expression level of Ikaros, Aiolos, and IRF4 transcription factors, in plasmablasts and early plasma cells...
May 10, 2016: Oncotarget
https://www.readbyqxmd.com/read/26933811/low-dose-tacrolimus-combined-with-donor-derived-mesenchymal-stem-cells-after-renal-transplantation-a-prospective-non-randomized-study
#7
Guang-Hui Pan, Zheng Chen, Lu Xu, Jing-Hui Zhu, Peng Xiang, Jun-Jie Ma, Yan-Wen Peng, Guang-Hui Li, Xiao-Yong Chen, Jia-Li Fang, Yu-He Guo, Lei Zhang, Long-Shan Liu
Calcineurin inhibitors, including tacrolimus, are largely responsible for advances in allotransplantation. However, the nephrotoxicity associated with these immunosuppressants impairs patients' long-term survival after renal allograft. Therefore, novel regimens that minimize or even eliminate calcineurin inhibitors could improve transplantation outcomes. In this pilot study, we investigated the use of low-dose tacrolimus in combination with mesenchymal stem cells (MSCs), which are immunosuppressive and prolong allograft survival in experimental organ transplant models...
March 15, 2016: Oncotarget
https://www.readbyqxmd.com/read/26536420/tolerance-induction-via-mixed-chimerism-in-vascularized-composite-allotransplantation-is-it-time-for-clinical-application
#8
REVIEW
Curtis L Cetrulo, Tessa Drijkoningen, David H Sachs
PURPOSE OF REVIEW: The present review summarizes current data on the induction of immunologic tolerance through mixed hematopoietic chimerism relevant to applying this approach to vascularized composite allotransplantation. RECENT FINDINGS: Clinical allograft tolerance has been achieved recently for kidney transplants, using nonmyeloablative conditioning regimens and bone marrow transplantation from living donors. The mixed chimerism attained in these studies was either transient or durable, and both permitted tolerance of the renal allografts to be achieved across MHC-matched and MHC-mismatched barriers...
December 2015: Current Opinion in Organ Transplantation
https://www.readbyqxmd.com/read/26467275/haploidentical-bone-marrow-transplantation-in-2015-and-beyond
#9
REVIEW
Guillermo J Ruiz-Argüelles, Guillermo J Ruiz-Delgado, Oscar González-Llano, David Gómez-Almaguer
On the face of the lack of HLA-identical sibling stem cell donors for all individuals needing an allograft, the use of alternative donors is gaining popularity. Matched unrelated donors and cord bloods have become very expensive and unaffordable for most people living in developing countries. Grafting allogeneic haploidentical stem cells has become an option with a great future, mainly if the procedure is conducted in a way to cut down expenses, such as the use of reduced-intensity conditioning regimens, outpatient conduction of the procedures, and use of post-transplant cyclophosphamide...
December 2015: Current Oncology Reports
https://www.readbyqxmd.com/read/26209354/pre-treatment-of-allogeneic-bone-marrow-recipients-with-the-cxcr4-antagonist-amd3100-transiently-enhances-hematopoietic-chimerism-without-promoting-donor-specific-skin-allograft-tolerance
#10
Zhanzhuo Li, Xin Xu, Ido D Weiss, Orit Jacobson, Philip M Murphy
Hematopoietic chimerism established by allogeneic bone marrow transplantation is known to promote donor-specific organ allograft tolerance; however, clinical application is limited by the need for toxic host conditioning and "megadoses" of donor bone marrow cells. A potential solution to this problem has been suggested by the observation that recipient bone marrow mobilization by the CXCR4 antagonist AMD3100 promotes chimerism in congenic bone marrow transplantation experiments in mice. Here we report that a single subcutaneous dose of 10 mg/kg AMD3100 in recipient C57BL/6 mice was able to enhance hematopoietic chimerism when complete MHC-mismatched BALB/c donor bone marrow cells were transplanted 1h after drug dosing...
October 2015: Transplant Immunology
https://www.readbyqxmd.com/read/26147679/clinical-trials-for-induction-of-renal-allograft-tolerance
#11
REVIEW
Nahel Elias, A Benedict Cosimi, Tatsuo Kawai
PURPOSE OF REVIEW: This review summarizes the current state of clinical trials for tolerance induction of human leukocyte antigen-matched or mismatched renal allografts via peritransplant infusion of donor bone marrow-derived products. Recent efforts to apply infusion of expanded regulatory T-cell preparations to minimize immunosuppressive dosages are also reviewed. RECENT FINDINGS: Three centers in the United States have reported clinical trials for tolerance induction in recipients of living donor kidney transplants via donor hematopoietic stem cell transplantation...
August 2015: Current Opinion in Organ Transplantation
https://www.readbyqxmd.com/read/25968127/a-novel-cryopreserved-viable-osteochondral-allograft-designed-to-augment-marrow-stimulation-for-articular-cartilage-repair
#12
Sandra Geraghty, Jin-Qiang Kuang, Dana Yoo, Michelle LeRoux-Williams, C Thomas Vangsness, Alla Danilkovitch
BACKGROUND: Here, we describe the design and characterization of a novel, cryopreserved, viable osteochondral allograft (CVOCA), along with evidence that the CVOCA can improve outcomes of marrow stimulation for articular cartilage repair. METHODS: Histological staining was performed to evaluate the CVOCA tissue architecture. CVOCAs were tested for the presence of extracellular matrix (ECM) proteins and chondrogenic growth factors using ELISA. Cell viability and composition were examined via live/dead staining, fluorescence-activated cell sorting (FACS) analysis, and immunofluorescence staining...
2015: Journal of Orthopaedic Surgery and Research
https://www.readbyqxmd.com/read/25725368/mesenchymal-stem-cell-allograft-as-a-fusion-adjunct-in-one-and-two-level-anterior-cervical-discectomy-and-fusion-a-matched-cohort-analysis
#13
Steven J McAnany, Junyoung Ahn, Islam M Elboghdady, Alejandro Marquez-Lara, Nomaan Ashraf, Branko Svovrlj, Samuel C Overley, Kern Singh, Sheeraz A Qureshi
BACKGROUND CONTEXT: Live mesenchymal stem cell (MSC) allograft-containing allogeneic bone grafts have recently gained popularity and currently account for greater than 17% of all bone grafts and bone graft substitutes used in spinal surgery. Although the claim of cellular bone matrices containing osteogenic cells with osteoinductive properties is attractive, little is known about their clinical success when used in anterior cervical discectomy and fusion (ACDF). PURPOSE: The objective of this study was to report on the radiographic fusion rates in one- and two-level instrumented ACDF using an MSC...
February 2016: Spine Journal: Official Journal of the North American Spine Society
https://www.readbyqxmd.com/read/25286051/anti-interleukin-6-receptor-antibodies-attenuate-antibody-recall-responses-in-a-mouse-model-of-allosensitization
#14
Irene Kim, Gordon Wu, Ning-ning Chai, Andrew S Klein, Stanley Jordan
BACKGROUND: Interleukin (IL)-6 is a regulatory cytokine for T helper type 17 (Th17) and Treg cells and a potent stimulus for B/plasma cells. The current study evaluated the effect of IL-6 receptor (IL-6R) blockade with an antiYIL-6R monoclonal (mMR16-1) in alloantibody recall responses. METHODS: A mouse model of human leukocyte antigen (HLA).A2 sensitization was used for studies to evaluate the efficacy of antiYIL-6R on alloantibody recall responses and to examine the impact of IL-6R blockade on Th17, Treg, follicular T helper (Tfh) and plasma cells using multiparameter flow cytometry, flow antibody binding, and enzyme-linked immunospot (ELISpot) assay...
December 27, 2014: Transplantation
https://www.readbyqxmd.com/read/25207262/infections-caused-by-mycobacterium-tuberculosis-in-recipients-of-hematopoietic-stem-cell-transplantation
#15
REVIEW
Khalid Ahmed Al-Anazi, Asma Marzouq Al-Jasser, Khalid Alsaleh
Mycobacterium tuberculosis (M. tuberculosis) infections are uncommon in recipients of hematopoietic stem cell transplantation. These infections are 10-40 times commoner in recipients of stem cell transplantation than in the general population but they are 10 times less in stem cell transplantation recipients compared to solid organ transplant recipients. The incidence of M. tuberculosis infections in recipients of allogeneic stem cell transplantation ranges between <1 and 16% and varies considerably according to the type of transplant and the geographical location...
2014: Frontiers in Oncology
https://www.readbyqxmd.com/read/24742484/bone-tissue-engineering-by-way-of-allograft-revitalization-mechanistic-and-mechanical-investigations-using-a-porcine-model
#16
COMPARATIVE STUDY
Christopher M Runyan, Samantha T Ali, Wendy Chen, Bennet W Calder, Aaron E Rumburg, David A Billmire, Jesse A Taylor
PURPOSE: "Allograft revitalization" is a process in which cadaveric bone is used to generate well-vascularized living bone. We had previously found that porcine allograft hemimandibles filled with autologous adipose-derived stem cells (ASCs) and recombinant human bone morphogenetic protein-2-soaked absorbable collagen sponge (rhBMP-2/ACS) were completely replaced by vascularized bone, provided the construct had been incubated within a periosteal envelope. The present study sought to deepen our understanding of allograft revitalization by investigating the individual contributions of ASCs and rhBMP-2 in the process and the mechanical properties of the revitalized allograft...
May 2014: Journal of Oral and Maxillofacial Surgery
https://www.readbyqxmd.com/read/24730250/scaffold-design-for-bone-regeneration
#17
REVIEW
Liliana Polo-Corrales, Magda Latorre-Esteves, Jaime E Ramirez-Vick
The use of bone grafts is the standard to treat skeletal fractures, or to replace and regenerate lost bone, as demonstrated by the large number of bone graft procedures performed worldwide. The most common of these is the autograft, however, its use can lead to complications such as pain, infection, scarring, blood loss, and donor-site morbidity. The alternative is allografts, but they lack the osteoactive capacity of autografts and carry the risk of carrying infectious agents or immune rejection. Other approaches, such as the bone graft substitutes, have focused on improving the efficacy of bone grafts or other scaffolds by incorporating bone progenitor cells and growth factors to stimulate cells...
January 2014: Journal of Nanoscience and Nanotechnology
https://www.readbyqxmd.com/read/24679209/treatment-of-humeral-shaft-aseptic-nonunions-in-elderly-patients-with-opposite-structural-allograft-bmp-7-and-mesenchymal-stem-cells
#18
Luigi Murena, Gianluca Canton, Ettore Vulcano, Michele Francesco Surace, Paolo Cherubino
Humeral shaft aseptic nonunions occur in 2% to 10% of patients managed conservatively and 10% to 15% of patients treated surgically. The complex muscular and neurovascular anatomy of the upper limb makes the surgical approach to the fracture site demanding and risky, especially when previous surgeries have been attempted. The clinical consequence of atrophic humeral shaft nonunions is a severe functional limitation that may significantly affect activities of daily living, especially in the elderly. The surgical treatment of humeral shaft nonunions is challenging for orthopedic surgeons...
February 2014: Orthopedics
https://www.readbyqxmd.com/read/24617969/multipotential-stromal-cell-abundance-in-cellular-bone-allograft-comparison-with-fresh-age-matched-iliac-crest-bone-and-bone-marrow-aspirate
#19
COMPARATIVE STUDY
Thomas G Baboolal, Sally A Boxall, Yasser M El-Sherbiny, Timothy A Moseley, Richard J Cuthbert, Peter V Giannoudis, Dennis McGonagle, Elena Jones
AIM: To enumerate and characterize multipotential stromal cells (MSCs) in a cellular bone allograft and compare with fresh age-matched iliac crest bone and bone marrow (BM) aspirate. MATERIALS & METHODS: MSC characterization used functional assays, confocal/scanning electron microscopy and whole-genome microarrays. Resident MSCs were enumerated by flow cytometry following enzymatic extraction. RESULTS: Allograft material contained live osteocytes and proliferative bone-lining cells defined as MSCs by phenotypic and functional capacities...
2014: Regenerative Medicine
https://www.readbyqxmd.com/read/24581253/properties-of-biologic-scaffolds-and-their-response-to-mesenchymal-stem-cells
#20
Knut Beitzel, Mary Beth McCarthy, Mark P Cote, Ryan P Russell, John Apostolakos, Daisy M Ramos, Sangamesh G Kumbar, Andreas B Imhoff, Robert A Arciero, Augustus D Mazzocca
PURPOSE: The purpose of this study was to examine, in vitro, the cellular response of human mesenchymal stem cells (MSCs) to sample types of commercially available scaffolds in comparison with control, native tendon tissue (fresh-frozen rotator cuff tendon allograft). METHODS: MSCs were defined by (1) colony-forming potential; (2) ability to differentiate into tendon, cartilage, bone, and fat tissue; and (3) fluorescence-activated cell sorting analysis (CD73, CD90, CD45)...
March 2014: Arthroscopy: the Journal of Arthroscopic & related Surgery
keyword
keyword
27930
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"